CD4 Lymphocytes
Summary of CD4 Lymphocytes
Primary Information, Benefits, Effects, and Important Facts
Scientific Information on CD4 Lymphocytes
Improve your health with the latest information on 400+ supplements and their effects on 600+ health outcomes.
By becoming an Examine Plus member, you'll have access to all of the latest nutrition research. Quickly and easily look up scientific research on over 400 supplements across over 600 different health goals, outcomes, conditions, and more.
Human Effect Matrix
The Human Effect Matrix looks at human studies (it excludes animal and in vitro studies) to tell you what supplements affect cd4 lymphocytes.
| Grade | Level of Evidence [show legend] |
|---|---|
|
Robust research conducted with repeated double-blind clinical trials |
|
Multiple studies where at least two are double-blind and placebo controlled |
|
Single double-blind study or multiple cohort studies |
|
Uncontrolled or observational studies only |
|
Level of Evidence
?
The amount of high quality evidence. The more
evidence, the more we can trust the results.
|
Supplement |
Magnitude of effect
?
The direction and size of the supplement's impact on
each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
|
Consistency of research results
?
Scientific research does not always agree. HIGH or
VERY HIGH means that most of the scientific research agrees.
|
Notes |
|---|---|---|---|---|
|
|
Minor
|
Low See all 4 studies |
While there does not appear to be any influence in healthy controls or with low dose colostrum, higher doses of colostrum in persons with HIV (reduced CD4+ lymphocyte counts) may mildly increase CD4+ counts when compared to whey protein as control.
|
|
|
|
Minor
|
- See study |
The decrease in the CD4:CD8 ratio seen with altitude training is attenuated with 2,500-5,000mg of the water soluble polysaccharides
|
|
|
|
- | - See study |
CD4+ Lymphocyte counts in subjects with HIV are not affected by alanylglutamine supplementation.
|
|
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
